Full Description
A comprehensive and up-to-date primer on the latest therapeutic advances in the management and treatment of epilepsy. This Includes practical information on diagnostic criteria for all different syndromes along with detailed discussions of appropriate agents.
Contents
Chapter 1Chapter 2: Epilepsy: Brief Historical Perspective Chapter 3: Definitions and Classification of Epilepsy and Seizures Chapter 4: Neurophysiologic Basis of Epileptiform ActivityChapter 5: EpidemiologyChapter 6: Magnetoencephalography in the Diagnosis and Treatment of EpilepsyChapter 7: Clinical Neurophysiology III: Other TechniquesChapter 8: Neuroimaging in EpilepsyChapter 9: Experimental Models of Seizures and EpilepsyChapter 10: The EEG of EpilepsyChapter 11: Genetic and Chromosomal Disorders in EpilepsyChapter 12: Neuropathology of Pediatric Cerebral Resections for EpilepsyChapter 13: Neurometabolic Disorders and EpilepsyChapter 14: Neurocutaneous Disorders and EpilepsyChapter 15: Neonatal SeizuresChapter 16: Epilepsy in Developmental Disorders Chapter 17: Epilepsy in Neurodegenerative DiseasesChapter 18: Acquired Lesions and EpilepsyChapter 19: Febrile SeizuresChapter 20: Convulsive Status EpilepticusChapter 21: Clinical Features, Diagnosis, and Treatment of Nonconvulsive Status EpilepticusChapter 22: Temporal Lobe Epilepsy SyndromesChapter 23: Partial-Onset Seizures and Localization-Related Epilepsy SyndromesChapter 24: Generalized Seizures and Generalized Epilepsy SyndromesChapter 25: Landau-Kleffner Syndrome and Language Dysfunction in EpilepsyChapter 26: Rasmussen EncephalitisChapter 27: Nonepileptic Paroxysmal DisordersChapter 28: Psychogenic Nonepileptic SeizuresChapter 29: Neurotransmitters and Drug Development in EpilepsyChapter 30: Antiepileptic Drugs: An OverviewChapter 31: Principles of Pharmacokinetics and Pharmacogenetics of AnticonvulsantsChapter 32: Pregnancy, Epilepsy, and Drug TreatmentChapter 33: Epileptic Drug Treatment in Special PopulationsChapter 34: Systemic Metabolic Consequences of Antiepileptic MedicationChapter 35: BarbituratesChapter 36: BenzodiazepinesChapter 37: Carbamazepine and OxcarbazepineChapter 38: EthosuximideChapter 39: Gabapentin and PregabalinChapter 40: LamotrigineChapter 41: LevetiracetamChapter 42: Phenytoin and FosphenytoinChapter 43: TopiramateChapter 44: Valproic AcidChapter 45: VigabatrinChapter 46: ZonisamideChapter 47: Other Antiepileptic DrugsChapter 48: Use of Antidepressants in Epilepsy:What All Neurologists Should KnowChapter 49: Immunotherapy in EpilepsyChapter 50: Dietary Therapy for EpilepsyChapter 51: Neurostimulation Therapy for EpilepsyChapter 52: Epilepsy SurgeryChapter 53: Prognosis and Ongoing Management of EpilepsyChapter 54: Neuropsychiatric Comorbidities with Epilepsy in Children and AdolescentsChapter 55: Epilepsy and CognitionChapter 56: Practical Treatment Strategies of Psychiatric Comorbidities in Adults with EpilepsyChapter 57: Therapeutic Uses of Seizures in NeuropsychiatryChapter 58: Social Challenges Among Children and Adolescents with Intractable EpilepsyChapter 59: Monitoring for Adverse Effects of Antiepileptic Drugs
